Sustained expression of ACTL6A in muscle cells hampers differentiation, while silencing ACTL6A in RMS cells increases the expression of muscle markers, inhibits cell proliferation, and suppresses tumor growth.33 The gene discussed is ACTL6A; the disease is neoplasm.